Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Oral Ozempic and a ‘miracle’ pill imitating the keto diet – a new era of weight loss is here
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they really work? Zoë Beaty looks at how the health landscape is rapidly changing to ...
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
24/7 Wall St. on MSN14d
Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
Kiplinger7mon
The Future of Weight-Loss Drugs for Investors
Traders are comparing U.S. weight-loss drug innovator Eli Lilly to artificial ... Baron ranks Structure second behind Lilly in the race to get a weight-loss pill to market. Structure is also ...
New York Post23d
Ozempic 3.0? This drug causes the greatest weight loss — by far
Eli Lilly’s retatrutide is called “triple G ... Liraglutide, a daily GLP-1 drug, brought weight loss of up to 5.8% after 26 weeks. A pill form of semaglutide brought similar weight loss ...
San Diego Union-Tribune29d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound ... increased physical activity and a reduced-calorie diet. Obstructive sleep apnea occurs when a person’s ...